Company Research Report: Auxilius

Company Overview

• Name: Auxilius

• Mission: Auxilius aims to help biotech companies manage the financial aspects of clinical trials to bring lifesaving therapies to the market cost-effectively.

• Founded by: No information is available.

• Key People:

• Adam Weisman, CEO and Co-founder

• Erin Warner Guill, Chief Operating Officer

• Laura Remaker, Chief People Officer

• Libby Hauser, SVP of Strategy

• Cem Oztas, VP of Engineering

• Jeremy Belcher, VP of Product

• Kristen Lueck, VP of Operations

• Sharon Langan, VP of Partnerships

• Wensheen Tong, VP, Revenue Operations

• Peter Kinchley, Head of Marketing

• Headquarters: No information is available.

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known for: Auxilius is known for its cloud-based Clinical Trial Financial Management (CTFM) software, which supports financial closing, budgeting, and spend analytics for life sciences companies. The company is SOC 1® Type 2 and SOC 2® Type 2 compliant.

Products

• Platform Solutions:

• Clinical & CMC Close Automation: This product accelerates period close with data-driven accrual estimates and compliant workflows.

• Study Budgeting and Dynamic Forecasting: This product leverages clinical drivers to keep study budgets up-to-date and plan for future clinical trial needs.

• Investigator Spend Intelligence: This product translates clinical data into accrual estimation, reforecasting, and site payment validation.

Recent Developments

• Funding:

• Auxilius recently raised $10 million in Series A funding, led by Renegade Partners, with participation from existing investors Bain Capital Ventures and XYZ Venture Capital. Angel investors such as Andy Palmer, Chase Gilbert, and Sam Whitaker also participated.

• New Products or Features:

• Auxilius introduced a Financial Planning & Analysis and Accounting software platform to unify clinical, contractual, and financial data for biotech companies. The platform serves needs across various company growth stages.

• Partnerships and Growth:

• Auxilius is expected to deploy its solution at 25 clients by the end of the year. The platform currently supports preclinical through phase 3 programs, with 45 distinct vendors and nearly $100 million in trial spending.

Conclusion

Auxilius provides a critical solution to the complex financial management of clinical trials, addressing a major need in the biotech industry. By centralizing financial workflows that support compliance, audit, and reporting requirements, Auxilius empowers biotech companies to efficiently manage financial risk and improve trial outcomes. The strategic funding and platform innovations signify Auxilius's commitment to facilitating cost-effective and efficient drug development processes.